The incidence of asthma is increasing at an alarming rate. While the current available therapies are effective, there are associated side effects and they fail to adequately control symptoms in all patient subsets. In the search to understand disease pathogenesis and find effective therapies hypotheses are often tested in animal models before progressing into clinical studies. However, current dogma is that animal model data is often not predictive of clinical outcome. One possible reason for this is the end points measured such as antigen-challenge induced late asthmatic response (LAR) is often used in early clinical development, but seldom in animal model systems. As the mouse is typically selected as preferred species for pre-clinical models, we wanted to characterise and probe the validity of a murine model exhibiting an allergen induced LAR. C57BL/6 mice were sensitised with antigen and subsequently topically challenged with the same antigen. The role of AlumTM adjuvant, glucocorticoid, long acting
Specific Challenges to Data Collection Data collection poses specific challenges, including accessibility, trust, and user motivation. The following sections discuss how these issues affected our design. Challenges of Accessibility Advocates … - Selection from Beautiful Data [Book]
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
The Respiratory Laboratory Scientist will explain and coach you through the testing process.. Test 1- Spirometry, Pre and Post bronchodilator:. This involves you blowing into a machine to see how much air you can blow out, how fast you can blow it out and whether or not it is better after administering a bronchodilator like Ventolin.. Test 2- Gas Diffusion (CO Uptake):. This test is used to determine the health of your lung tissue. It investigates how effectively oxygen is able to pass across the lung membrane and into the blood stream. This test involves you breathing into a machine and holding your breath.. Test 3- Bronchial Provocation Tests:. This test is performed to diagnose whether or not you have asthma. It simply involves you inhaling a spray or fine sugar powder at low, controlled doses to test the sensitivity of your airways.. Test 4- Exercise test for oxygen supplementation:. This is also known as a 6 Minute Walk Test and your doctor may wish for you to have one in order to see how ...
Concentration of methacholine (mg/ml) at which participants forced expired volume in 1 sec (FEV1) is reduced by 20% (the provocation concentration of methacholine causing a 20% fall in FEV1-PC20).. To measure if there is a significant difference in PC20 recorded at baseline to that recorded following 8 weeks treatment with omeprazole and ranitidine ...
Our study made a preliminary demonstration that the finding of obstruction based on the FEV1/FVC in the setting of a normal FEV1 (defined in this study as greater than 90% of predicted) does not consistently represent a normal physiologic variant. Nearly 28% of tested patients met criteria for AHR by either BD response or bronchoprovocation testing, irrespective of the presence or absence of symptoms. While there were no significant differences in AHR for those patients with an FEV1 , 100% of predicted versus ≥ 100% of predicted, the overall trend demonstrated a decreased frequency of AHR for an FEV1 ≥ 100% of predicted, as 80% of patients with evidence of AHR had an FEV1 , 100%. This becomes important in correlating the clinical suspicion for underlying disease with the indication (screening vs symptomatic) for PFT. Conversely, even in the presence of active pulmonary symptoms or established diagnoses, nearly 75% of patients tested did not demonstrate a significant BD response. This might ...
Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble interleukin-2 receptor, and interleukin-6 in asthmatic children ...
TY - JOUR. T1 - Methacholine inhalation challenge studies in a selcted pediatric population. AU - Hopp, R. J.. AU - Bewtra, A. K.. AU - Nair, N. M.. AU - Watt, G. D.. AU - Townley, R. G.. PY - 1986. Y1 - 1986. N2 - To determine bronchial reactivity patterns, 400 subjects, 5 to 21 yr of age, underwent a methacholine challenge in a Natural History of Asthma study. The diagnosis of asthma or allergy was based on a respiratory questionnaire. Subjects were nonsmokers and had had no respiratory infections for 1 month. Intradermal skin tests were done. The methacholine challenge response was expressed as the area beneath the dose-response curve (Area35). Fifty-five asthmatics, 113 normal subjects from normal families, 103 normal subjects from asthma families, 60 normal twins, and 69 allergic subjects without asthma were studied. Overall, 52% of nonasthmatics and 47% of nonallergic subjects had an Area35 less than 4,000 (800 breath units). There was a difference (p , 0.05) in the distribution of ...
Bronchial hyperresponsiveness (or other combinations with airway or hyperreactivity) is a state characterised by easily triggered bronchospasm (contraction of the bronchioles or small airways). Bronchial hyperresponsiveness can be assessed with a bronchial challenge test. This most often uses products like methacholine or histamine. These chemicals trigger bronchospasm in normal individuals as well, but people with bronchial hyperresponsiveness have a lower threshold. Bronchial hyperresponsiveness is a hallmark of asthma but also occurs frequently in people suffering from chronic obstructive pulmonary disease (COPD). In the Lung Health Study, bronchial hyperresponsiveness was present in approximately two-thirds of patients with non-severe COPD, and this predicted lung function decline independently of other factors. In asthma it tends to be reversible with bronchodilator therapy, while this is not the case in COPD. Bronchial hyperresponsiveness has been associated with gas cooking among subjects ...
Bronchial hyperresponsiveness (or other combinations with airway or hyperreactivity) is a state characterised by easily triggered bronchospasm (contraction of the bronchioles or small airways).. Bronchial hyperresponsiveness can be assessed with a bronchial challenge test. This most often uses products like methacholine or histamine. These chemicals trigger bronchospasm in normal individuals as well, but people with bronchial hyperresponsiveness have a lower threshold.. Bronchial hyperresponsiveness is a hallmark of asthma but also occurs frequently in people suffering from chronic obstructive pulmonary disease (COPD). In the Lung Heart Study, bronchial hyperresponsiveness was present in approximately two-thirds of patients with non-severe COPD, and this predicted lung function decline independently of other factors. In asthma it tends to be reversible with bronchodilator therapy, while this is not the case in COPD. ...
[Studies with experimental bronchospasm (histamine provocation test) for determination of the efficacy of an antihistaminic]. - H M Beumer
This is a Phase 3 study to determine the sensitivity and specificity of the Aridol bronchial challenge test to detect bronchial hyperresponsiveness in patients with suspected asthma. Patients with suspected asthma of either gender, aged between 6 and 50 years, with only mildly impaired lung function (FEV1 ,70%) are to be tested with three different bronchial hyperresponsiveness challenges (Aridol, exercise and methacholine), and the results compared. A clinical diagnosis will also be made at the end of the study ...
TY - JOUR. T1 - Investigative bronchoprovocation and bronchoscopy in airway diseases. AU - Busse, William W.. AU - Wanner, Adam. AU - Adams, Kenneth. AU - Reynolds, Herbert Y.. AU - Castro, Mario. AU - Chowdhury, Badrul. AU - Kraft, Monica. AU - Levine, Robert J.. AU - Peters, Stephen P.. AU - Sullivan, Eugene J.. PY - 2005/10/1. Y1 - 2005/10/1. N2 - Rationale: Basic and clinical research strategies used for many lung diseases have depended on volunteer subjects undergoing bronchoscopy to establish access to the airways to collect biological specimens and tissue, perhaps with added bronchoprovocation in asthma syndromes. These procedures have yielded a wealth of important scientific information. Since the last critical review more than a decade ago, some of the techniques and applications have changed, and untoward events have occurred, raising safety concerns and increasing institutional review scrutiny. Objectives and Methods:To reappraise these investigational methods in the context of ...
Asthma is a heterogeneous disease and clinical phenotypes are highly variable. This is exemplified in the variability of patients responses to medications such as beclomethasone. It is a critical clinical question whether a particular therapy will be effective in an individual child with symptoms of asthma. At the moment, there is a lack of diagnostic tools to assess this individual responsiveness. Beclomethasone is an inhaled corticosteroid (ICS) used as controller therapy in children with asthma, providing protection against bronchial hyperresponsiveness (BHR) and exercise induced bronchoconstriction (EIB). A single dose of an ICS can have a significant effect on BHR measured by a bronchial provocation test (BPT). This rapid response shows variability similar to the variable responsiveness to long term treatment. We hypothesized that the effect of a single dose of beclomethasone on a BPT (a mannitol challenge) could predict the effect of longterm therapy with beclomethasone on BHR ...
Dr. Anand responded: Methacholine test. The test result is available as soon as the test is completed. It can take half to one hour. A physician has to interpret the test results. Some times the answer may not be clear cut.
Walsh SL, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, Nunes H, Valeyre D, Brillet PY, Kambouchner M, Morais A, Pereira JM, Moura CS, Grutters JC, van den Heuvel DA, van Es HW, van Oosterhout MF, Seldenrijk CA, Bendstrup E, Rasmussen F, Madsen LB, Gooptu B, Pomplun S, Taniguchi H, Fukuoka J, Johkoh T, Nicholson AG, Sayer C, Edmunds L, Jacob J, Kokosi MA, Myers JL, Flaherty KR, Hansell DM, Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study., Lancet respiratory, 2016;:557-565,10.1016/S2213-2600(16)30033-9 ...
Smiths Medical Asthma Patient Testing Kit (Methacholine Bronchoprovocation) is a convenient, all-inclusive procedural kit for the assessment of the respiratory
TY - JOUR. T1 - Histamine forming capacity (HFC) and its modulation by H3 receptor ligands in a model of bronchial hyper-responsiveness. AU - Allen, Marcus. AU - Graham, P.. AU - Morris, G.. PY - 1996/3/1. Y1 - 1996/3/1. M3 - Article. VL - 45. SP - 118. EP - 122. JO - Inflammation Research. JF - Inflammation Research. SN - 1023-3830. IS - 3. ER - ...
Vandenplas O, Suojalehto H, Aasen T, Baur X, Burge PS, de Blay F, Fishwick D, Hoyle J, Maestrelli P, Muñoz X, Moscato G, Sastre J, Sigsgaard T, Suuronen K, Walusiak-Skorupa J, Cullinan P, the ERS Task Force on Specific Inhalation Challenges with Occupational Agents, Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement, Eur Respir J, 2014;43:1573-1587 ...
Occupational asthma (OA) is steadily emerging as the principal cause of respiratory disease due to the workplace environment. One of the key means to ascertain diagnosis of OA is specific inhalation challenge (SIC) with occupational agents. This review: 1) describes the methodology of SIC, with a special emphasis on procedures aimed at increasing the safety and validity of these tests; and 2) outlines the roles of SIC in the diagnosis of OA in clinical and medicolegal assessment, epidemiological studies, surveillance programmes and the investigation of the pathophysiological mechanisms of asthma and OA. We discuss areas of future development, including the development of apparatus which allows exposure of subjects to low and stable concentrations of the occupational agent and the assessment of preventive procedures.. ...
CiteSeerX - Scientific documents that cite the following paper: Diesel exhaust enhances airway responsiveness in asthmatic subjects
TY - JOUR. T1 - Assessment of bronchial responsiveness following exposure to inhaled occupational and environmental agents. AU - Currie, G. P.. AU - Ayres, Jonathan Geoffrey. PY - 2004. Y1 - 2004. M3 - Article. VL - 23. SP - 75. EP - 81. JO - Toxicology. JF - Toxicology. SN - 0300-483X. ER - ...
Bronchoprovocation challenge testing is sometimes used to diagnose asthma if your lung function is normal but you have typical asthma symptoms.
Methacholine tests are widely used as a diagnostic aid for asthma. Their strength has been reputed to be the high sensitivity and very infrequent occurrence of ...
The curators will assemble challenge teams to address specific global issues in the developing and developed worlds, with short- and long-term goals for tackling pressing issues where serious progress is possible.. "Solving the worlds most pressing challenges depends in part on the kind of daring innovations and ideas that MIT is known for - and in fields from water, food, energy, and human health to innovation and education, our faculty are pioneering new answers," MIT Provost Martin Schmidt says. "But lasting solutions to intractable human problems demand ambitious, sustained collaborative action, and require, from us, new ways of working with the world. Through Solve, we are connecting new ideas for action with people who, together, have the power to spark and accelerate meaningful change.". The Solve event will include challenge working groups, student forums, and tours. The specific challenges associated with each pillar will be addressed at the Solve event, and work will continue ...
Welcome to Real Science Real Nutrition! In an effort to bring our customers the highest level of quality products at affordable prices, we have developed an online store that offers added convenience to our customers. We know that natural medicines, vitamins, and herbs play a key role in supporting many of the bodys functions. Whether youre looking to support cardiovascular function, immune function, digestion, or the specific challenges that men and women face, we have a targeted solution for you. Real Science Real Nutrition offers a complete line of professionally formulated, high quality nutritional and dietary supplements at your fingertips. With quick and safe shipping, your health and wellness products can be delivered right to your front door!
Welcome to Real Science Real Nutrition! In an effort to bring our customers the highest level of quality products at affordable prices, we have developed an online store that offers added convenience to our customers. We know that natural medicines, vitamins, and herbs play a key role in supporting many of the bodys functions. Whether youre looking to support cardiovascular function, immune function, digestion, or the specific challenges that men and women face, we have a targeted solution for you. Real Science Real Nutrition offers a complete line of professionally formulated, high quality nutritional and dietary supplements at your fingertips. With quick and safe shipping, your health and wellness products can be delivered right to your front door!
While drinking trends for Whites tend to dominate views of overall drinking trends for the United States, Blacks and Hispanics often face specific challenges
MicroRNAs are small non-coding RNAs that regulate gene expression at the post-transcriptional level. While they have been implicated in various diseases, the profile changes in allergen inhalation challenge are not clarified in human. We aimed to evaluate changes in the microRNA profiles in the peripheral blood of asthmatic subjects undergoing allergen inhalation challenge. Seven mild asthmatic subjects participated in the allergen inhalation challenge. In addition, four healthy control subjects (HCs) were recruited. MicroRNA profiles in peripheral blood samples (pre-challenge and 2 hours post-challenge) were measured by the NanoString nCounter assay to determine changes in miRNA levels as these asthmatic subjects underwent an allergen inhalation challenge. One common miRNA, miR-192, was significantly expressed in both comparisons; HCs vs. pre-challenge and pre- vs. post-challenge, showing that miR-192 was significantly under-expressed in asthmatics compared to HCs and decreased in post-challenge at an
It was recently reported that caffeine may reduce the clinical symptoms of asthma and may prevent the clinical manifestations of this disease. The effect of caffeine on histamine responsiveness is unknown. The effect of caffeine (5 mg/kg) and placebo on histamine responsiveness (the provocation concentration causing a 20% fall in FEV1, PC20) was studied in 10 subjects with mild asthma (prechallenge FEV1 84% of predicted value). The PC20 for histamine bronchoprovocation after caffeine ingestion was 2.65 (95% confidence limits 0.99, 7.10) mg/ml. After placebo the PC20 was 1.89 (0.96, 3.71) mg/ml. It is concluded that caffeine in a dose equivalent to about three cups of coffee has a very small effect, if any, on histamine bronchoprovocation in those with mild asthma. Specific instructions about not having drinks containing caffeine before histamine challenge are therefore not necessary.. ...
Bronchial challenge tests are used to evaluate bronchial responsiveness in diagnosis and follow-up of asthmatic patients. Challenge induced cough has increasingly been recognized as a valuable diagnostic tool. Various stimuli and protocols have been employed. The aim of this study was to compare cough and dyspnea intensity induced by different stimuli. Twenty asthmatic patients underwent challenge tests with methacholine, bradykinin and exercise. Cough was counted during challenge tests. Dyspnea was assessed by modified Borg scale and visual analogue scale. Statistical comparisons were performed by linear mixed-effects model. For cough evaluation, bradykinin was the most potent trigger (p | 0.01). In terms of dyspnea measured by Borg scale, there were no differences among stimuli (p | 0.05). By visual analogue scale, bradykinin induced more dyspnea than other stimuli (p ≤ 0.04). Bradykinin seems to be the most suitable stimulus for bronchial challenge tests intended for measuring cough in association
In a study of 14 subjects with respiratory symptoms associated with exposure to live fish bait, skin- and serum-specific IgE tests with Lucilia caesar, Galleria mellonella, and Tenebrio molitor extracts were conducted. Thirteen subjects had asthma, all 14 had rhinoconjunctivitis, and 3 had contact urticaria. Eleven subjects had respiratory symptoms after fishing with live bait, and 3 subjects had symptoms during their work in a commercial fish bait farm. The presence of skin- or serum-specific IgE to L. caesar extract was demonstrated in 13 subjects, to G. mellonella extract in 4 subjects, and to T. molitor extract in 3 subjects. After exposure to live fish bait, 2 subjects had an early asthmatic response, 3 had a late asthmatic response, and 2 had no asthmatic response. Late asthmatic response was associated with a long-lasting increase in bronchial responsiveness (8 ...
Wheezing during infancy has been linked to early loss of pulmonary function. We prospectively investigated the relation between bronchial hyperresponsiveness (BHR) and progressive impairment of pulmonary function in a cohort of asthmatic infants followed until age 9 years. We studied 129 infants who had had at least three episodes of wheezing. Physical examinations, baseline lung function tests and methacholine challenge tests were scheduled at ages 16 months and 5, 7 and 9 years. Eighty-three children completed follow-up. Twenty-four (29%) infants had wheezing that persisted at 9 years of age. Clinical outcome at age 9 years was significantly predicted by symptoms at 5 years of age and by parental atopy. Specific airway resistance (sRaw) was altered in persistent wheezers as early as 5 years of age, and did not change thereafter. Ninety-five per cent of the children still responded to methacholine at the end of follow-up. The degree of BHR at 9 years was significantly related to current clinical status
A number of mechanisms have been proposed as the basis for the relationship between nonspecific airway responsiveness and prechallenge pulmonary function. Because resistance to flow through a tube is inversely proportional to the radius to the fourth power, a given degree of bronchoconstrictor-induced circumferential airway narrowing can be expected to cause a proportionally larger increase in airway resistance in a narrow airway than in a wider airway. Intersubject differences in the distribution of resistance along the bronchial tree may influence both the pattern of aerosol deposition and the relative impact on total airway resistance of bronchoconstriction at particular sites such as the peripheral airways. Airway hyperresponsiveness may result in heightened bronchomotor tone prior to challenge and thereby be correlated with reduced prechallenge pulmonary function. The convention of expressing responsiveness in terms of percentage of change in FEV, (eg, PD20FEV,) imposes a mathematical ...
TY - JOUR. T1 - Noninvasive quantification of airway inflammation following segmental allergen challenge with functional MR imaging. T2 - A proof of concept study. AU - Renne, Julius. AU - Hinrichs, Jan. AU - Schönfeld, Christian. AU - Gutberlet, Marcel. AU - Winkler, Carla. AU - Faulenbach, Cornelia. AU - Jakob, Peter. AU - Schaumann, Frank. AU - Krug, Norbert. AU - Wacker, Frank. AU - Hohlfeld, Jens M.. AU - Vogel-Claussen, Jens. PY - 2015/1/1. Y1 - 2015/1/1. N2 - Purpose: To evaluate oxygen-enhanced T1-mapping magnetic resonance (MR) imaging as a noninvasive method for visualization and quantification of regional inflammation after segmental allergen challenge in asthmatic patients compared with control subjects.Materials and After institutional review board approval, nine asthmatic Methods: and four healthy individuals gave written informed consent. MR imaging (1.5 T) was performed by using an inversion-recovery snapshot fast low-angle shot sequence before (0 hours) and 6 hours and 24 hours ...
The neurosurgical team has complete and primary control of the patients in the NICU and is therefore very closely involved in their management. Comprehensive monitoring capability is already in place and an excellent full-time research coordinator is on staff. The adult and pediatric hospital buildings are adjacent to each other and are connected by a cross walk. The same resident team covers both age groups. There is an excellent working relationship between the Neurosurgery team, the Trauma Surgery team and other associated services. Cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2879175 • Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Author(s): Leuppi JD, Brannan JD, Anderson SD. Source: Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology. 2002 April 6; 132(13-14): 151-8. Review. cmd=Retrieve&db=pubmed&dopt=A ...
The 547 asymptomatic subjects with normal pulmonary function were grouped according to quintile of prechallenge FEV, (percent predicted), and the fifth percentiles of PD20FEV, within each quintile of FEV, were calculated (Table 2). The fifth percentile of methacholine PD20FEV, increased with increasing quintile of prechallenge FEV,. This relationship is shown graphically in Figure 1, in which the fifth percentile of PD20FEV, for each quintile is plotted against the median FEV, for that quintile. Restricting analysis to a subgroup of 157 lifetime nonsmokers yielded similar values for the fifth percentiles of PD20FEV,, for both overall and FEV,-specific percentiles (data not shown). canadian health & care mall. The overall fifth percentile of PD20FEV, (8.3 (imol) and the FEV,-specific fifth percentiles of PD20FEV, (as indicated in Table 2) respectively defined the 26 (4.8 percent) and 27 (4.9 percent) most responsive subjects among the 547 asymptomatic men. Seventeen (3.1 percent) men were ...
The aim of this study was to assess the effectiveness of an asthma prevalence video questionnaire, a standard written questionnaire based on the IUATLD Bronchial Symptoms Questionnaire and a new written questionnaire designed for an international study of asthma and allergies in childhood ISAAC in predicting bronchial hyper-responsiveness BHR...
TY - JOUR. T1 - Removal of bronchoalveolar cells augments the late eosinophilic response to segmental allergen challenge. AU - Hunt, L. W.. AU - Gleich, G. J.. AU - Kita, H.. AU - Weiler, D. A.. AU - Schroeder, D. R.. AU - Vuk Pavlovic, Z.. AU - Sur, Sanjiv. PY - 2002. Y1 - 2002. N2 - Background: In patients with quiescent asthma, macrophages are the most prevalent cells recovered by bronchoalveolar lavage (BAL). Through activation via their FcεRII receptors or by acting as antigen-presenting cells, macrophages could, in theory, promote the late airway response to allergen. Objective: In order to investigate the importance of macrophages and other airway luminal cells in inducing the late airway response, a novel washout experiment was designed. Methods: Five patients with ragweed-allergic asthma underwent bronchoscopy and segmental bronchial challenge with either normal saline or short ragweed extract in two segments of one lung. In a third segment of the opposite lung, 12 successive BALs ...
BACKGROUND: It has been postulated that dietary antioxidants may influence the expression of allergic diseases and asthma. To test this hypothesis a case-control study was performed, nested in a cross sectional study of a random sample of adults, to investigate the relationship between allergic disease and dietary antioxidants. METHODS: The study was performed in rural general practices in Grampian, Scotland. A validated dietary questionnaire was used to measure food intake of cases, defined, firstly, as people with seasonal allergic-type symptoms and, secondly, those with bronchial hyperreactivity confirmed by methacholine challenge, and of controls without allergic symptoms or bronchial reactivity. RESULTS: Cases with seasonal symptoms did not differ from controls except with respect to the presence of atopy and an increased risk of symptoms associated with the lowest intake of zinc. The lowest intakes of vitamin C and manganese were associated with more than fivefold increased risks of ...
Using a sensitive single isotope enzymatic assay we measured bronchoalveolar lavage (BAL) fluid histamine in asymptomatic normal (nonallergic), allergic rhinitic, and allergic asthmatic subjects. Normal subjects were found to have little or no detectable amounts of histamine in BAL fluid (11 +/- 11 pg/ml), and few BAL fluid mast cells. In comparison, the allergic rhinitics and allergic asthmatics had much higher amounts of BAL fluid histamine (113 +/- 53 and 188 +/- 42 pg/ml, respectively), and a significantly greater number of BAL fluid mast cells. Furthermore, despite having equivalent baseline pulmonary function values, allergic asthmatics with BAL fluid histamine levels greater than 100 pg/ml required only 7 +/- 2 breath units of methacholine to induce a 20% drop in forced expiratory volume in 1 s (FEV1) (PD20FEV1) while asthmatics with BAL fluid histamine levels less than 100 pg/ml required 49 +/- 19 breath units (P less than 0.05). These data suggest that allergic asthmatics have ongoing ...
PubMed journal article Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary diseas were found in PRIME PubMed. Download Prime PubMed App to iPhone or iPad.
Quilizumab, a humanized IgG1 monoclonal antibody, targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells. In patients with mild asthma, quilizumab reduced serum IgE and attenuated the early and late asthmatic reaction following whole lung allergen challenge. This study evaluated the efficacy and safety of quilizumab in adults with allergic asthma, inadequately controlled despite high-dose inhaled corticosteroids (ICS) and a second controller. Five hundred seventy-eight patients were randomized to monthly or quarterly dosing regimens of subcutaneous quilizumab or placebo for 36 weeks, with a 48-week safety follow-up. Quilizumab was evaluated for effects on the rate of asthma exacerbations, lung function, patient symptoms, serum IgE, and pharmacokinetics. Exploratory analyses were conducted on biomarker subgroups (periostin, blood eosinophils, serum IgE, and exhaled nitric oxide). Quilizumab was well tolerated and reduced serum total and allergen
the history of asthma asthma tests for adults types of asthma mild persistent treatment for asthma asthma and anxiety asthma coughing dry asthma specialists richmond asthma tests methacholine symptoms of asthma in cats skin asthma clinic A bronchial challenge test is a medical test used to assist in the diagnosis...
Lung function assessments are critical to confirm a diagnosis of asthma and to assess for alternative diagnosis and comorbidity. Assessments include spirometry, bronchial provocation testing, forced oscillation technique and peak expiratory flow.
The contributions of histamine, cysteinyl leukotrienes (CysLTs) and thromboxane A,SUB,2,/SUB, (TXA,SUB,2,/SUB,) to the asthmatic responses and the magnitudes of blood and lung eosinophilia at acute and chronic stages of our asthmatic model were comparatively determined. Guinea pigs were alternately sensitized/challenged by inhalation with ovalbumin+Al(OH),SUB,3,/SUB, and ovalbumin, once every 2 weeks. Effects of mepyramine, pranlukast (a CysLT antagonist) and seratrodast (a TXA,SUB,2,/SUB, antagonist) on the early (EAR) and/or the late asthmatic response (LAR) were assessed at the second and fourth antigen challenges. The second challenge caused EAR but not LAR. Although the EAR was decreased at the fourth challenge, a substantial LAR was seen. Both mepyramine and seratrodast inhibited the EAR at the second challenge by approximately 50%. However, at the fourth challenge, these drugs did not inhibit the EAR. The LAR at the fourth challenge was attenuated by pranlukast and seratrodast by 45% and ...
The aim of this study was to assess prevalence of asthma and allergy in the non-polluted mountain area of Upper Hallingdal, Norway. All schoolchildren (7-16 years) who in a previous questionnaire survey (n = 1177) reported sometime asthma were enrolled in group I (n = 80), the 59 who reported asthma-like symptoms in the past 12 months formed group II, and 77 of the healthy controls were randomly selected as group III. All 216 children underwent clinical examination, skin prick test, spirometry, bronchial provocation (PD20 metacholine) and treadmill exercise test. Subsequently they were reclassified as (1) healthy, never had asthma or symptoms, (2) symptoms not confirmed as asthma, (3) previous asthma, now healthy, (4) current asthma. Lifetime asthma prevalence was 10.2%. Based upon clinical examination, the specificity and sensitivity of the questionnaire for asthma diagnosis were 88 and 74%, respectively. Forced vital capacity was significantly higher among the asthmatics (group 4 versus 1), ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
In order to diagnose and monitor asthma, your healthcare provider examines you. He or she listens to your chest and asks you to breathe. You are asked questions about your symptoms, triggers, and any family history of asthma or allergies. Special lung function tests may also be done. One of these is called a spirometry test.. ...
Our study investigated if airway hyperresponsiveness (AHR) at asthma onset could predict FEV1 decline in treated asthmatics. We retrospectively recruited 275 subjects that had performed a methacholine test at asthma onset and FEV1 measurements after 5-10 years. We subdivided subjects into three groups, according to their AHR level. 65 patents had normal reactivity (25 males; mean age 46±15; mean baseline FEV1%:96.1±20); 78 were borderline/mild AHR (PD20,400µg) (26 males; mean age 43±14; mean baseline FEV1%:102±12; mean PD20:1120±696) and 132 showed moderate/severe AHR (PD20≤400µg; 51 males; mean age 43±14; mean baseline FEV1%: 94±13; mean PD20:185±108). Annual FEV1 declines (the differences between the first and last measurements, divided by the number of years separating them) were compared. Average annual FEV1 declines (after 7±2 years) were similar in all groups: 46.2±81 ml/yr in normal reactivity subjects, 53±65 in borderline/mild AHR and 45±62.5 in moderate/severe AHR ...